NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa.
N-terminal (NT) pro-brain natriuretic peptide (proBNP) > or =160 ng/l has a 78% positive predictive value for pulmonary hypertension and is associated with increased mortality in US sickle cell disease patients, but the importance in sickle cell disease patients in Africa is not known. In a cross-sectional study at Ahmadu Bello University Teaching Hospital, Shika-Zaria, Nigeria, we studied 133 hydroxycarbamide-naïve Nigerian sickle cell anaemia patients aged 18-52 years at steady-state and 65 healthy controls. Twenty-six percent of patients versus 5% of controls had NT-proBNP > or =160 ng/l (P = 0.0006). By logistic regression among the patients, human immunodeficiency virus seropositivity, higher serum ferritin and lower haemoglobin or higher lactate dehydrogenase independently predicted elevated NT-proBNP. After adjustment for haemoglobin concentration, elevated NT-proBNP concentration was associated with an estimated 7.8-fold increase in the odds of severe functional impairment, defined as an inability to walk more than 300 m in 6 min (95% confidence interval 1.5-32.6; P = 0.005). Similarly, elevated tricuspid regurgitation velocity was associated with an estimated 5.6-fold increase in the odds of functional impairment (95% confidence interval 1.5-21.0; P = 0.011). In conclusion, NT-proBNP elevation is common and is associated with markers of anaemia, inflammation and iron status and with severe functional impairment among sickle cell anaemia patients in Nigeria.
Aliyu
Zakari Y
ZY
Taraba State Specialist Hospital, Jalingo, Nigeria.
Suleiman
Aisha
A
Attah
Ester
E
Mamman
Aisha I
AI
Babadoko
Aliyu
A
Nouraie
Mehdi
M
Mendelsohn
Laurel
L
Kato
Gregory J
GJ
Gordeuk
Victor R
VR
Gladwin
Mark T
MT
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D015415:Biomarkers / Q000097:blood; D003430:Cross-Sectional Studies; D005080:Exercise Test / Q000379:methods; D006801:Humans; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011379:Prognosis; D014262:Tricuspid Valve Insufficiency / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D016138:Walking / Q000502:physiology; D055815:Young Adult
D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain
Intern Med J. 2009 Aug;39(8):495-501
19732197
J Am Coll Cardiol. 2007 Jan 30;49(4):472-9
17258093
Blood. 2003 Feb 15;101(4):1257-61
12393669
N Engl J Med. 2005 Feb 17;352(7):666-75
15716560
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
16376782
J Am Soc Echocardiogr. 2002 Feb;15(2):167-84
11836492
J Am Coll Cardiol. 2004 Mar 3;43(5):764-70
14998614
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):487-92
10673190
Haematologica. 2007 Jun;92(6):738-43
17550845
Circulation. 1997 Jul 15;96(2):509-16
9244219
N Engl J Med. 2004 Feb 26;350(9):886-95
14985486
JAMA. 1993 Oct 13;270(14):1702-7
8411500
Am J Med. 2004 Nov 1;117(9):665-9
15501204
Am J Hematol. 2008 Jan;83(1):63-70
17910044
Blood. 2006 Mar 15;107(6):2279-85
16291595
JAMA. 2006 Jul 19;296(3):310-8
16849664
Ann Trop Med Parasitol. 2007 Jan;101(1):3-14
17244405
Genomics. 1996 Apr 15;33(2):167-76
8660964
Circulation. 2005 Dec 6;112(23):3602-7
16330702
Am J Hematol. 2008 Jun;83(6):485-90
18306362
Science. 2002 Dec 13;298(5601):2133-4
12481120